Tachykinins protect cholinergic neurons from quinolinic acid excitotoxicity in striatal cultures

Brain Research

Volumn 740, Issue 1-2, 1996, Pages 323-328

  Calvo, Nancy ^a   Reiriz, Julia ^a   Pérez Navarro, Esther ^a   Alberch, Jordi ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

acetylcholinesterase; choline acetyltransferase activity; kainic acid; neurokinin; neuroprotection; neurostriatum; rat; substance P

Indexed keywords

6 CYANO 7 NITRO 2,3 QUINOXALINEDIONE; ACETYLCHOLINESTERASE; CHOLINE ACETYLTRANSFERASE; DIZOCILPINE; EXCITOTOXIN; KAINIC ACID; NEURON SPECIFIC ENOLASE; NEUROPROTECTIVE AGENT; QUINOLINIC ACID; RECEPTOR SUBTYPE; SUBSTANCE P; SUBSTANCE P DERIVATIVE; TACHYKININ; TACHYKININ RECEPTOR ANTAGONIST;

ANIMAL CELL; ARTICLE; CELL CULTURE; CHOLINERGIC NERVE CELL; CONTROLLED STUDY; CORPUS STRIATUM; ENZYME ACTIVITY; FETUS; IMMUNOCYTOCHEMISTRY; NERVE DEGENERATION; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; CELLS, CULTURED; CHOLINERGIC FIBERS; CORPUS STRIATUM; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; NEUROPROTECTIVE AGENTS; PREGNANCY; QUINOLINIC ACID; RATS; RATS, SPRAGUE-DAWLEY; TACHYKININS;

EID: 0030592745     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(96)00879-7     Document Type: Article

References (46)

1. [1] Alberch, J., Arenas, E., Pérez-Navarro, E. and Marsal, J., Control of tachykinin-evoked acetylcholine release from rat striatal slices by dopaminergic neurons, Naunyn-Schmiedeberg's Arch. Pharmacol., 348 (1993) 445-449.
2. [2] Arenas, E., Alberch, J., Pérez-Navarro, E., Solsona, C. and Marsal, J., Neurokinin receptors differentially mediate endogenous acetylcholine release evoked by tachykinins in the neostriatum, J. Neurosci., 11 (1991) 2332-2338.
3. [3] Arenas, E., Pérez-Navarro, E., Alberch, J. and Marsal, J., Selective resistance of tachykinin-responsive cholinergic neurons in the quinolinic acid lesioned neostriatum, Brain Res., 603 (1993) 317-320.
4. [4] Barker, R., Substance P and neurodegenerative disorders. A speculative review, Neuropeptides, 20 (1991) 73-78.
5. [5] Bernard, V., Legay, C., Massoulie, J. and Bloch, B., Anatomical analysis of the neurons expressing the acetylcholinesterase gene in the rat brain, with special reference to the striatum, Neuroscience, 64 (1995) 995-1005.
6. [6] Bolam, J.P., Ingham, C.A., Izzo, P.N., Rye, D.B., Smith, A.D. and Wainer, B.H., Substance P-containing terminals in synaptic contact with cholinergic neurons in the neostriatum and basal forebrain: a double immunocytochemical study in the rat, Brain Res., 397 (1991) 279-289.
7. 3H]senktide, Brain Res., 506 (1990) 175-179.
8. [8] DiFiglia, M., Excitotoxic injury of the neostriatum: a model for Huntington's disease, Trends Neurosci., 13 (1990) 286-289.
9. [9] Fonnum, F.A., Rapid radiochemical method for the determination of choline acetyltransferase, J. Neurochem., 24 (1975) 407-409.
10. [10] Franklin, J.L. and Johnson, Jr E.M., Suppression of programmed neuronal death by sustained elevation of cytoplasmic calcium, Trends Neurosci., 15 (1992) 501-508.
11. [11] Freese, A., DiFiglia, M., Koroshetz, W.J., Beal, M.F. and Martin, J.B., Characterization and mechanism of glutamate neurotoxicity in primary striatal cultures, Brain Res., 521 (1990) 254-264.
12. [12] Friedman, W.J., Dreyfus, C.F., McEwen, B. and Black, I.B., Presynaptic transmitters and depolarizing influences regulate development of the substantia nigra in culture, J. Neurosci., 8 (1988) 3616-3623.
13. [13] Gerfen, C.R., Substance P (neurokinin-1) receptor mRNA is selectively expressed in cholinergic neurons and basal forebrain, Brain Res., 556 (1991) 165-170.
14. [14] Gerfen, C.R., The neostriatal mosaic: Multiple levels of compartmental organization in the basal ganglia, Annu. Rev. Neurosci., 15 (1992) 285-320.
15. [15] Ghosh, A., Carnahan, J. and Greenberg, M.E., Requirement for BDNF in activity-dependent survival of cortical neurons, Science, 263 (1994) 1618-1623.
16. [16] Grafe, M.R., Forno, L.S. and Eng, L.F., Immunocytochemical studies of substance P and Met-enkephalin in the basal ganglia and substantia nigra in Huntington's, Parkinson's and Alzheimer's disease, J. Neuropath. Exp. Neurol., 44 (1985) 47-59.
17. [17] Guard, S. and Watson, S.P., Tachykinin receptor types: classification and membrane signalling mechanisms, Neurochem. Int., 18 (1991) 149-165.
18. [18] Guevara Guzman, R., Kendrick, K.M. and Emson, P.C., Effect of substance P on acetylcholine and dopamine release in the rat striatum: a microdialysis study, Brain Res., 622 (1993) 147-154.
19. [19] Hefti, F., Hartikka, J., Eckenstein, F., Gnahn, H., Heumann, R. and Schwab, M., Nerve growth factor increases choline acetyltransferase but not survival or fiber outgrowth of cultured fetal septal cholinergic neurons, Neuroscience, 14 (1985) 55-68.
20. 7,9)-substance P, an analogue with substance P antagonistic activity, Acta. Physiol. Scand., 113 (1981) 571-573.
21. [21] Hong, J.S., Yang, H.-Y.T., Racagni, G. and Costa, E., Projections of substance P containing neurons from neostriatum to substantia nigra, Brain Res., 122 (1977) 541-544.
22. [22] Iwasaki, Y., Kinoshita, M., Ikeda, K., Takamiya, K. and Shiojima, T., Trophic effect of various neuropeptides on the cultured ventral spinal cord of rat embryo, Neurosci. Lett., 101 (1989) 316-320.
23. [23] Jonsson, G. and Hallman, H., Substance P counteracts neurotoxin damage on norepinephrine neurons in rat brain during ontogeny, Science, 215 (1982) 75-77.
24. [24] Kanazawa, I., Emson, P.C. and Cuello, A.C., Evidence for the existence of substance P containing fibres in striato-nigral and pallido-nigral pathways in rat brain, Brain Res., 119 (1977) 447-453.
25. [25] Kaneko, T., Shigemoto, R., Nakanishi, S. and Mizuno, N., Substance P receptor-immunoreactive neurons in the rat neostriatum are segregated into somatostatinergic and cholinergic aspiny neurons, Brain Res., 631 (1993) 297-303.
26. [26] Kim, J.P. and Choi, D.W., Quinolinate neurotoxicity in cortical cell culture, Neuroscience, 23 (1987) 423-432.
27. [27] Koh, J.Y. and Choi, D.W., Cultured striatal neurons containing NADPH-diaphorase or acetylcholinesterase are selectively resistant to injury by NMDA receptor agonists, Brain Res., 446 (1988) 374-378.
28. [28] Kowall, N.W., Beal, M.F., Busciglio, J., Duffy, L.K. and Yankner, B.A., An in vivo model for neurodegenerative effects of β-amyloid and protection by substance P, Proc. Natl. Acad. Sci. USA, 88 (1991) 7247-7251.
29. [29] Lindholm, D., Castrén, E., Berzaghi, M., Blöchl, A. and Thoenen, H., Activity-dependent and hormonal regulation of neurotrophin mRNA levels in the brain. Implications for neuronal plasticity, J. Neurobiol., 25 (1994) 1362-1372.
30. [30] Lu, B., Yokoyama, M., Dreyfus, C.F. and Black, I.B., Depolarizing stimuli regulate nerve growth factor gene expression in cultured hippocampal neurons, Proc. Natl. Acad. Sci. USA, 88 (1991) 6289-6292.
31. [31] Maggio, J.E., Tachykinins, Annu. Rev. Neurosci., 11 (1988) 13-28.
32. [32] Marione, M.E., Armstrong, D.M., Young, S.J. and Groves, P.M., Cholinergic neurons are distributed preferentially in areas rich in substance P-like immunoreactivity in the caudate nucleus of the adult cat, Neuroscience, 56 (1993) 567-579.
33. 1-11, Neuroscience, 48 (1992) 595-605.
34. [34] Narumi, S. and Maki, Y., Stimulatory effects of substance P on neurite extension and cyclic AMP levels in cultured neuroblastoma cells, J. Neurochem., 30 (1978) 1321-1326.
35. [35] Otsuka, M. and Yoshioka, K., Neurotransmitter functions of mammalian tachykinins, Physiol. Rev., 73 (1993) 229-308.
36. [36] Pérez-Navarro, E. and Alberch, J., Protective role of nerve growth factor against excitatory amino acid injury during neostriatal cholinergic neurons postnatal development, Exp. Neurol., 135 (1995) 146-152.
37. [37] Pérez-Navarro, E., Alberch, J. and Marsal, J., Postnatal development of functional dopamine, opioid and tachykinin receptors that regulate acetylcholine release from rat neostriatal slices. Effect of 6-hydroxydopamine lesion, Int. J. Dev. Neurosci., 11 (1993) 701-708.
38. [38] Pérez-Navarro, E., Alberch, J., Arenas, E., Calvo, N. and Marsal, J., Nerve growth factor and basic fibroblast growth factor protect cholinergic neurons against quinolinic acid excitotoxicity in rat neostriatum, Eur. J. Neurosci., 6 (1994) 706-711.
39. [39] Post, C. and Paulsson, I., Antinociceptive and neurotoxic actions of substance P analogues in the rat's spinal cord after intrathecal administration, Neurosci. Lett., 57 (1985) 159-164.
40. [40] Quirion, R. and Dam, T.V., Multiple neurokinin receptors: recent developments, Regul. Peptides, 22 (1988) 18-25.
41. 3, ligands) in the rat brain, Peptides, 9 (1988) 227-241.
42. [42] Schwartz, J.P. and Taniwaki, T., Heterogeneity of expression of neuropeptide genes by astrocytes: Functional implications, Perspect. Dev. Neurobiol., 2 (1994) 251-257.
43. [43] Shigemoto, R., Nakaya, Y., Noruma, S., Ogawa-Meguro, R., Ohishi, H., Kaneko, T., Nakanishi, S. and Mizuno, N., Immunocytochemical localization of rat substance P receptor in the striatum, Neurosci. Lett., 153 (1993) 157-160.
44. 1) gene expression in rat astrocytes in vitro, Neurosci. Lett., 182 (1994) 185-187.
45. [45] Whitty, C.J., Kapatos, G. and Bannon, M.J., Neurotrophic effects of substance P on hippocampal neurons in vitro, Neurosci. Lett., 164 (1993) 141-144.
46. [46] Yankner, B.A., Duffy, L.K. and Kirschner, D.A., Neurotrophic and neurotoxic effects of amyloid β-protein: reversal by tachykinin neuropeptides, Science, 250 (1990) 279-282.